Discordant CAR-T cell signaling: implications of divergence from physiological T cell activation
Abstract Chimeric antigen receptor (CAR) T cell therapy constituted a recent breakthrough in the treatment of poor prognosis cancers by harnessing therapeutic T cells with an engineered non-MHC restricted antigen recognition transgene. CAR constructs are expressed in addition to endogenous T cell re...
Saved in:
| Main Authors: | Pablo Gonzalez-Garcia, Noelia Moares, Isabel Serrano-García, Ricardo Fernandez-Cisnal, Rosa Luna-Espejo, Javier Ocaña-Cuesta, Wenjie Yi-He, Juan P. Muñoz-Miranda, Antonio Gabucio, Cecilia M. Fernandez-Ponce, Francisco Garcia-Cozar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06857-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual targeting of BCMA and SLAMF7 with the CARtein system: chimeric antigen receptors with intein-mediated splicing elicit specific T cell activation against multiple myeloma
by: Noelia Moares, et al.
Published: (2025-07-01) -
The conserved ATPase PCH-2 controls the number and distribution of crossovers by antagonizing their formation in Caenorhabditis elegans
by: Bhumil Patel, et al.
Published: (2025-02-01) -
Toll-like receptor 4 signaling activation domains promote CAR T cell function against solid tumors
by: Veronika Mikolič, et al.
Published: (2024-06-01) -
SLAMF7 (CD319) enhances cytotoxic T-cell differentiation and sensitizes CD8+ T cells to immune checkpoint blockade
by: Jan-Erik Sander, et al.
Published: (2025-08-01) -
One-Year Outcomes After Belatacept Conversion in Adolescent Kidney Transplant Recipients
by: Charlotte Duneton, et al.
Published: (2025-06-01)